Krystn Hammond joins Grant Thornton as CFO Advisory principal

15-year valuation and transaction veteran tapped to help clients across the life sciences industry

 

 

CHICAGO — Grant Thornton, one of America’s largest brands for audit, assurance, tax, and advisory services, today announced that Krystn Hammond has joined the firm as a CFO Advisory principal within the Advisory Services practice.

 

With more than 15 years of experience, Hammond has advised pharmaceutical and life sciences clients on transactions and tax restructurings, including acquisitions, divestitures, spin-offs and intellectual property migrations. Her experience spans across industry subsectors, such as big pharma, biotech, medical devices and diagnostics, generics, specialty, animal health, consumer and services.

 

As a member of Grant Thornton’s Valuation and Modeling team, Hammond will focus on assisting life sciences clients with comprehensive valuation solutions that center on measuring value while helping organizations make better, more informed decisions.

 

“From advising on transactions to providing solutions across all life sciences subsectors, Krystn brings more than a decade of knowledge and skill to Grant Thornton’s CFO Advisory practice,” said Paul Melville, national managing principal of CFO Advisory at Grant Thornton Advisors LLC. “Her extensive experience helping organizations make strategic and thoughtful decisions will provide immense value for our firm and the clients we serve.”

 

Zara Muradali, national Life Sciences leader at Grant Thornton Advisors LLC, echoed Melville’s sentiment on the value Hammond’s experience will bring to Grant Thornton’s clients.

 

“The life sciences industry is constantly evolving, and our clients deserve quality-driven solutions that provide value to their businesses,” said Muradali. “Krystn’s wealth of life sciences knowledge will help strengthen our industry offerings and provide our clients with tailored services that meet their unique needs.”

 

Prior to joining Grant Thornton, Hammond worked as a healthcare investment banker focused on strategic mergers and acquisitions at Stifel, via its acquisition of Torreya Capital, where she advised on transactions across generics, specialty pharma, complex formulations and infectious diseases. She also served as a director in PwC’s Deals practice, where she focused on life sciences and led the firm’s middle-market clients and opportunities initiative for the sector in the New York metro region.

 

“I’m grateful to be part of a firm that sets exemplary standards in everything from client service to company culture,” said Hammond about her new role at Grant Thornton. “I look forward to working with a team of dynamic valuation professionals to help our life sciences clients make well-informed strategic decisions to add value to both patients and shareholders.”

 

Based in New York, Hammond has served on the Junior Council of the American Ballet Theatre and as audit committee chair and treasurer of an international ballet scholarship competition. She is also a member of the Apollo Circle of the Metropolitan Museum of Art. Hammond received a bachelor’s degree in finance and master’s degree in accounting from the A.B. Freeman School of Business at Tulane University. She is a Chartered Financial Analyst (CFA) charterholder and a certified public accountant in New York.

 

To learn more about Grant Thornton’s CFO advisory services offerings, visit: www.grantthornton.com/services/advisory-services/cfo-advisory.